Phase I–II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer
Open Access
- 1 April 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (4) , 493-496
- https://doi.org/10.1023/a:1011199028318
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumoursCancer Chemotherapy and Pharmacology, 2000
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual dataThe Lancet, 2000
- Liposomal Doxorubicin and Conventionally Fractionated Radiotherapy in the Treatment of Locally Advanced Non–Small-Cell Lung Cancer and Head and Neck CancerJournal of Clinical Oncology, 1999
- Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor modelsAnti-Cancer Drugs, 1999
- Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long-circulating pegylated stealth liposomesInternational Journal of Cancer, 1999
- Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing miceCancer Chemotherapy and Pharmacology, 1999
- Treatment of cancer with radiation and drugs.Journal of Clinical Oncology, 1996